Cargando…

ACE Gene Polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients

We examined the renal responsiveness to ACE inhibitor in IgA nephropathy (IgAN) patients according to the grouping of ACE gene polymorphism. Sixty one patients diagnosed as IgAN by renal biopsy and prescribed with ACE inhibitors were enrolled. Genomic DNA was extracted from whole blood and PCR was p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Sang Youb, Kwon, Young Joo, Jo, Sang Kyung, Shin, Jin Ho, Cha, Dae Ryong, Cho, Won Yong, Pyo, Heui Jung, Kim, Hyoung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2000
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531733/ https://www.ncbi.nlm.nih.gov/pubmed/10714086 http://dx.doi.org/10.3904/kjim.2000.15.1.13

Ejemplares similares

Effect of IgA Aggregates on Transforming Growth Factor-β1 Production in Human Mesangial Cells and the Intraglomerular Expression of Transforming Growth Factor-β1 in Patients with IgA Nephropathy
por: Han, Sang-Youb, et al.
Publicado: (2005)

The Influence of ACE Insertion/Deletion Gene Polymorphism on the Risk of IgA Nephropathy: A Debatable Topic
por: Chu, Fen-Fen, et al.
Publicado: (2021)

Clinical Course of Patients with IgA Nephropathy between Combined Treatment of Immunosuppressive Agents and ACE Inhibitor and ACE Inhibitor alone
por: Hwang, You-Cheol, et al.
Publicado: (2001)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

The Association between Serum Hemoglobin and Renal Prognosis of IgA Nephropathy
por: Oh, Tae Ryom, et al.
Publicado: (2021)

The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females
por: Oh, Tae Ryom, et al.
Publicado: (2020)

ACE Insertion/Deletion Polymorphism and Diabetic Nephropathy: Clinical Implications of Genetic Information
por: Ha, Sung-Kyu
Publicado: (2014)

Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients
por: Cha, Yoon Jin, et al.
Publicado: (2016)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Long-term prognosis of clinically early IgA nephropathy is not always favorable
por: Lee, Hajeong, et al.
Publicado: (2014)

Plasmaphresis therapy for pulmonary hemorrhage in a pediatric patient with IgA nephropathy
por: Yim, Dae-Kyoon, et al.
Publicado: (2015)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Renal vascular lesions in IgA nephropathy
por: Baradaran, Azar
Publicado: (2013)

IgA Nephropathy – Beyond the Renal Cortex
por: Kirushnan, Balaji, et al.
Publicado: (2023)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA Nephropathy
por: Chin, Ho Jun, et al.
Publicado: (2009)

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy
por: Han, Sang Youb, et al.
Publicado: (2021)

Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome
por: Kim, Sun Moon, et al.
Publicado: (2009)

Immunological abnormalities in patient with IgA nephropathy.
por: Ihm, C. G., et al.
Publicado: (1986)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy
por: Suh, Kwang-Sun, et al.
Publicado: (2019)

ACE polymorphism in asthmatic patients
por: Cortez, Margarida, et al.
Publicado: (2013)

The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
por: Han, Sang Youb, et al.
Publicado: (2023)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

Tuberculosis-associated IgA nephropathy
por: Wang, Yamei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c7plq3knkn6n7csq99fcivn071